Literature DB >> 11215565

Occult hepatitis B virus infection.

G Raimondo1, C Balsano, A Craxì, F Farinati, M Levrero, M Mondelli, T Pollicino, G Squadrito, C Tiribelli.   

Abstract

Many studies have shown that hepatitis B virus infection may also occur in hepatitis B surface antigen-negative patients. This occult infection has been identified both in patients with cryptogenic liver disease and in patients with hepatitis C virus-related chronic hepatitis, and much evidence suggests that it may be a risk factor of hepatocellular carcinoma development. However several aspects of this occult infection remain unclear such as its prevalence and the factor(s) involved in the lack of circulating hepatitis B surface antigen. Moreover, it is uncertain whether the occult hepatitis B virus infection may contribute to chronic liver damage, considering that it is usually associated with a suppressed viral replication. Evidence and hypotheses concerning this fascinating field of bio-medical research are reviewed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11215565     DOI: 10.1016/s1590-8658(00)80362-x

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

Review 1.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 2.  Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants.

Authors:  Hong Kim; Bum-Joon Kim
Journal:  Int J Mol Sci       Date:  2015-06-15       Impact factor: 5.923

3.  Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals.

Authors:  Hong Kim; Jeong-Ryeol Gong; Seoung-Ae Lee; Bum-Joon Kim
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.